Baudax Bio Inc.

0.8200+0.0559+7.32%Vol 374.49K1Y Perf -7.38%
Jun 27th, 2022 16:00 DELAYED
BID0.8060 ASK0.8400
Open0.7779 Previous Close0.7641
Pre-Market- After-Market0.82
 - -  - -%
Target Price
8.00 
Analyst Rating
Strong Buy 1.00
Potential %
875.61 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     37.10
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
0.52 
Earnings Rating
Market Cap5.27M 
Earnings Date
4th Aug 2022
Alpha-0.14 Standard Deviation0.27
Beta2.07 

Today's Price Range

0.76310.8900

52W Range

0.670029.71

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
6.87%
1 Month
8.44%
3 Months
-52.05%
6 Months
230.25%
1 Year
-7.38%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BXRX0.82000.05597.32
AAPL141.660.00000.00
GOOG2 332.45-38.3100-1.62
MSFT264.89-2.8100-1.05
XOM89.032.13002.45
WFC40.24-0.5200-1.28
JNJ182.12-0.1700-0.09
FB196.640.99000.51
GE66.71-0.2900-0.43
JPM116.38-0.9400-0.80
Earnings HistoryEstimateReportedSurprise %
Q01 2022-1.85-3.17-71.35
Q04 2021-10.04-
Q03 2021-5.59-6.99-25.04
Q02 2021-7.69-7.344.55
Q01 2021-6.64-6.640.00
Q03 2020-29.37-25.1714.30
Q02 2020-0.74-0.740.00
Q01 2020-0.91-0.838.79
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th Aug 2022
Estimated EPS Next Report-1.27
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume374.49K
Shares Outstanding6.42K
Shares Float6.37M
Trades Count1.26K
Dollar Volume306.40K
Avg. Volume160.66K
Avg. Weekly Volume129.89K
Avg. Monthly Volume152.27K
Avg. Quarterly Volume199.82K

Baudax Bio Inc. (NASDAQ: BXRX) stock closed at 0.82 per share at the end of the most recent trading day (a 7.32% change compared to the prior day closing price) with a volume of 374.49K shares and market capitalization of 5.27M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 57 people. Baudax Bio Inc. CEO is Gerri A. Henwood.

The one-year performance of Baudax Bio Inc. stock is -7.38%, while year-to-date (YTD) performance is 274.09%. BXRX stock has a five-year performance of %. Its 52-week range is between 0.67 and 29.7115, which gives BXRX stock a 52-week price range ratio of 0.52%

Baudax Bio Inc. currently has a PE ratio of -0.20, a price-to-book (PB) ratio of 0.50, a price-to-sale (PS) ratio of 4.04, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -29.22%, a ROC of -134.53% and a ROE of -413.49%. The company’s profit margin is -%, its EBITDA margin is -1 271.70%, and its revenue ttm is $1.30 Million , which makes it $0.20 revenue per share.

Of the last four earnings reports from Baudax Bio Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-1.27 for the next earnings report. Baudax Bio Inc.’s next earnings report date is 04th Aug 2022.

The consensus rating of Wall Street analysts for Baudax Bio Inc. is Strong Buy (1), with a target price of $8, which is +875.61% compared to the current price. The earnings rating for Baudax Bio Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Baudax Bio Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Baudax Bio Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 25.28, ATR14 : 0.07, CCI20 : 81.96, Chaikin Money Flow : 0.00, MACD : -0.08, Money Flow Index : 46.56, ROC : 6.35, RSI : 40.24, STOCH (14,3) : 73.52, STOCH RSI : 1.00, UO : 55.19, Williams %R : -26.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Baudax Bio Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Baudax Bio Inc.

Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.

CEO: Gerri A. Henwood

Telephone: +1 484 395-2470

Address: 490 Lapp Road, Malvern 19355, PA, US

Number of employees: 57

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

58%42%

Bearish Bullish

54%46%

TipRanks News for BXRX

Fri, 06 May 2022 12:05 GMT Analysts Offer Insights on Healthcare Companies: Baudax Bio (BXRX) and Axcella Health (AXLA)

- TipRanks. All rights reserved.

Mon, 04 Apr 2022 12:25 GMT Analysts Offer Insights on Healthcare Companies: Onconova Therapeutics (ONTX), Baudax Bio (BXRX) and 4d Pharma (LBPS)

- TipRanks. All rights reserved.

Mon, 28 Feb 2022 13:05 GMT Analysts Offer Insights on Healthcare Companies: Baudax Bio (BXRX) and Ocugen (OCGN)

- TipRanks. All rights reserved.

Wed, 05 Jan 2022 11:17 GMT Baudax Bio (BXRX) Gets a Buy Rating from Noble Financial

- TipRanks. All rights reserved.

News

Stocktwits